Navigation Links
Good News For Those Of You Suffering From Rheumatoid Arthritis

Combination therapy with the new biologic drug adalimumab and methotrexate has been found to be about five times more effective for people with long-standing rheumatoid arthritis when compared to the usual management // with methotrexate alone. It has been found to decrease pain and swelling in patients who fail to respond to standard treatment.

At the end of the 6-month trial, 43 percent of all subjects on adalimumab plus methotrexate had achieved a 50-percent improvement in symptoms, compared with 9 percent of all subjects receiving placebo plus methotrexate. In addition, adalimumab injections slowed progression of joint damage as revealed by joint X-rays.

Rheumatoid arthritis is an autoimmune disease, which develops when certain cells of the immune system malfunction and attack healthy joints. The cause of rheumatoid arthritis is unknown. The primary focus of the inflammation is in the synovium, the lining tissue of the joint. Inflammatory chemicals released by the immune cells cause swelling and damage to cartilage and bone.

Adalimumab works by preventing a protein called tumor necrosis factor (TNF) from signaling the release of joint-damaging substances. Adalimumab is approved for the treatment of moderate to severe rheumatoid arthritis in adults who do not respond to other treatments.

Addressing future research priorities, long-term efficacy and safety studies are needed before this therapy can be put into clinical practice.


'"/>




Page: 1

Related medicine news :

1. Identifying Those At Risk For Diabetes
2. Identifying Those At Risk For Diabetes
3. Hope For Those With Pancreatic Cancer
4. Good News For Those Suffering From Excessive Sweating
5. Cell Implants May Help Those Who Suffer From Parkinsons
6. Firms Told To Employ Those With Aspergers Syndrome
7. Statins Prescribed To Those Who Are At a Risk Of Developing A Heart Disease
8. Adventure Enthusiasts, Risk Takers and Those Living on the Edge, Good News Coming Your Way
9. Number of Allergic Anaphylaxis Episodes Are Far More Than Those Recorded
10. Korea: No Discrimination against Those with AIDS/HIV in the Workplace
11. Free Herceptin Treatment for Those Who Live Over the Welsh Border
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... Fla. (PRWEB) , ... October 12, 2017 , ... IsoComforter, ... therapy products, announced today the introduction of an innovative new design of the shoulder ... pad so you get maximum comfort while controlling your pain while using cold therapy. ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 ... ... Company, Cal Dining at the University of California Berkeley, and other leading institutions ... leverages the buying power of institutions to change the way animals are raised ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017   ... for global supply chains, has published the first annual edition of its ... of more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings ... 2016. ... CSR Risk & Performance Index ...
Breaking Medicine Technology: